Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow SYK
Stryker Corporation (SYK) Net income
Stryker Corporation's net income for fiscal 2025 was $3.2B, up 8.45% from $3.0B in fiscal 2024. Over the twelve months to 30 June 2026 it was $3.7B. Over the past ten years it has ranged from $1.0B (fiscal 2017) to $3.6B (fiscal 2018); the current reading is higher than 91% of that period. Stryker Corporation ranks 3rd of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $3.2B | 8.45% |
| FY2024 | $3.0B | (5.43%) |
| FY2023 | $3.2B | 34.22% |
| FY2022 | $2.4B | 18.25% |
| FY2021 | $2.0B | 24.70% |
| FY2020 | $1.6B | (23.24%) |
| FY2019 | $2.1B | (41.37%) |
| FY2018 | $3.6B | 248.33% |
| FY2017 | $1.0B | (38.07%) |
| FY2016 | $1.6B | 14.45% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $1.3B | 71.28% |
| Mar 2026 | $745.0M | (12.25%) |
| Dec 2025 | $849.0M | (1.16%) |
| Sep 2025 | $859.0M | (2.83%) |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| ABT Abbott Laboratories compare | $5.4B |
| MDT Medtronic PLC compare | $5.3B |
| SYK Stryker Corporation | $3.7B |
| BSX Boston Scientific Corporation compare | $3.7B |
| GEHC GE HealthCare Technologies Inc. compare | $2.1B |
| PHG Koninklijke Philips N.V. compare | $1.3B |
| EW Edwards Lifesciences Corporation compare | $1.0B |
| DXCM DexCom, Inc. compare | $999.7M |
| STE STERIS plc compare | $808.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on SYK
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement